Core Viewpoint - DiagnaMed Holdings Corp. has issued 3,000,000 restricted share units (RSUs) and 2,500,000 stock options to its directors, officers, and consultants as part of its equity incentive plan to align leadership interests with shareholders and reward contributions to the company's growth [1][2]. Group 1: Issuance Details - The stock options have an exercise price of $0.05 per share and are exercisable for three years from the date of grant [3]. - All RSUs and options are subject to the terms of the company's equity incentive plan and applicable regulatory approvals [3]. Group 2: Strategic Direction - The grants reflect the Board's confidence in the strategic direction of the company, particularly in advancing its natural hydrogen projects in Ontario with partners INRS and QIMC [4]. - DiagnaMed is committed to driving innovation and growth in the natural hydrogen sector in Ontario [4]. Group 3: Operational Initiatives - The company continues to advance its hydrogen development initiatives and enhance operational execution, strategically scaling its platform to capitalize on growth opportunities in the expanding natural hydrogen sector [5]. - This includes the ongoing deployment of the QIMC and INRS teams in Northern Ontario [5]. Group 4: Company Overview - DiagnaMed Holdings Corp. specializes in advanced hydrogen extraction technologies aimed at supporting the growing natural hydrogen industry, focusing on commercial scalability and delivering cost-effective, sustainable hydrogen solutions [6].

TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("”DiagnaMed” or “DMED") (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, today announced the appointment of John Karagiannidis as President and Chief Executive Officer, succeeding Fabio Chianelli, who is stepping down from his executive positions but will remain actively involved as a member of the Board of Directors. Mr. Karagiannidis In his continued role as President ...

TORONTO, June 05, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, is pleased to announce its recent strategic acquisition in Ontario, serving as a critical proof of concept for the Company's proprietary hydrogen extraction technology, directly aligning with its commitment to clean hydrogen energy solutions. Neither the Canadian Securities Exchange nor its Re ...

Core Insights - DiagnaMed Holdings Corp. has strategically acquired 91 unpatented mineral claims totaling 1820 hectares in Ontario's Temiscamingue hydrogen district, enhancing its position in a promising natural hydrogen region [1][2] - The acquisition allows for operational synergies and technical collaboration with Quebec Innovative Materials Corp. (QIMC), which is located adjacent to the newly acquired claims [2] - The acquisition agreement includes a non-refundable payment of $25,000 and the issuance of 12.5 million common shares, along with a 2.0% royalty on revenues from hydrogen or other minerals sold from the property [3] Company Strategy - The acquisition is expected to accelerate the commercialization of DiagnaMed's proprietary hydrogen extraction technologies, providing a competitive edge in the market [4] - The collaboration with QIMC is anticipated to foster innovation and commercialization in the Temiscamingue region, aligning with both companies' commitment to sustainable energy solutions [4] Market Context - The Temiscamingue region is recognized for its favorable geological conditions for natural hydrogen generation, presenting significant potential for technology validation and commercial development for DiagnaMed [2]